Knockdown of cancerous inhibitor of protein phosphatase 2A may sensitize metastatic castration-resistant prostate cancer cells to cabazitaxel chemotherapy-Reference-Cited by-同舟云学术

Knockdown of cancerous inhibitor of protein phosphatase 2A may sensitize metastatic castration-resistant prostate cancer cells to cabazitaxel chemotherapy

Published:2014-11-07 Issue:3 Volume:36 Page:1589-1594
ISSN:1010-4283
Container-title:Tumor Biology
language:en
Short-container-title:Tumor Biol.

Author:

Huang Jinming,Jia Jiaoyuan,Tong Qiang,Liu Jun,Qiu Jun,Sun Rong,Yao Lixin,Yang Chun

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s13277-014-2748-5.pdf

Reference23 articles.

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics. CA Cancer J Clin. 2009;59:225–49.

2. Ren SC, Chen R, Sun YH. Prostate cancer research in China. Asian J Androl. 2013;15:350–3.

3. Huggins C, Hodges CV. Studies on prostatic cancer: I. The effect of castration, of estrogen, and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941. J Urol. 2002;168(1):9–12.

4. Suzman DL, Antonarakis ES. Castration-resistant prostate cancer: latest evidence and therapeutic implications. Ther Adv Med Oncol. 2014;6(4):167–79.

5. Lassi K, Dawson NA. Update on castrate-resistant prostate cancer. Curr Opin Oncol. 2010;22:263–7.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From Basic Science to Clinical Practice: The Role of Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A)/p90 in Cancer;Frontiers in Genetics;2023-02-24

2. Prostate Cancer Disparities and Management in Southern Africa: Insights into Practices, Norms and Values;Cancer Management and Research;2022-12

3. CIP2A as a Key Regulator for AKT Phosphorylation Has Partial Impact Determining Clinical Outcome in Breast Cancer;Journal of Clinical Medicine;2022-03-14

4. Therapies Targeted to Androgen Receptor Signaling Axis in Prostate Cancer: Progress, Challenges, and Hope;Cancers;2019-12-23

5. Synergistic Interaction of HOXB13 and CIP2A Predisposes to Aggressive Prostate Cancer;Clinical Cancer Research;2018-09-04